Facilitating Access to Approved Medication

Bosutinib Tablets 500 mg
Bosutinib Tablets is used to treat chronic myeloid leukemia (CML) that is Philadelphia chromosome-positive (Ph+) in patients who are newly-diagnosed or who have used other treatments that did not work well. Leukemia is a type of cancer where the body makes abnormal white blood cells.

Get Access To Bosutinib Tablets 500 mg

Bosutinib Tablets was approved for medical use in the United States in 2017. It is on the World Health Organization’s List of Essential Medicines. It is available as a generic medication.

Bosutinib-Tablets Available Price In India UK Saudi Arabia

Bosutinib Tablets

  • Innovator Name – On Request
  • Generic Brand Available – On Request
  • API – Bosutinib
  • Packaging – 30 Tablets
  • Strength – 500 mg

What is bosutinib used for?

Bosutinib Tablets is a small molecule BCR-ABL and src tyrosine kinase inhibitor indicated for the treatment of:

Chronic Myelogenous Leukemia: For those patients who are adults and carrying Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.

Bosutinib has also shown activity against the receptors for platelet-derived growth factor and vascular endothelial growth factor.


    All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

    Get Access To Bosutinib Tablets 500 mg

    Shreyaansh Lifesciences, Jaipur. India

    Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act. 
    Branch Offices in India : Jaipur | New Delhi

    SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.

    +91 99292 77766

    Facts of Medicines

    Bosutinib Tablets 500 mg


    Care should be exercised in the handling of BOSUVI. BOSUVI tablets should not be opened or crushed. Store permitted between 15-30°C (59-86°F).


    Bosutinib 500mg should be taken orally at about the same time each day, either with or without food. Bosutinib tablets should be swallowed whole with water. The tablets should not be opened, broken, or chewed.


    • The most common adverse reactions include Nausea, Myelosuppression, Vomiting, Abdominal pain, Raised ALT, Raised AST, Rash, Arthralgia (joint pain), Fever, Oedema, Fatigue, Cough, Headache, Reduced appetite, Respiratory tract infection and Diarrhoea.
    • Some other common side effects of Bosutinib include Acne, Itchiness, Hives, Myalgia (muscle aches), Back pain, Kidney failure, Chest pain, Pain, Muscle weakness, Shortness of breath, Dizziness, Dehydration, and Drug hypersensitivity.


    • The use of Bosutinib is contraindicated for the, known hypersensitivity to bosutinib and liver impairment.
    • Need to monitor liver enzymes at least every month in order to the initial three months and as needed. Withhold, dose reduce, or discontinue BOSULIF.
    • Patients should be monitored for renal function at baseline and also during the therapy with BOSUVI.
    • Females of reproductive potential should avoid becoming pregnant while being treated with Bosutinib. The medication may cause fetal harm.
    • All the patients should be monitored and also should be managed by using standard of care treatment.
    • If you’re willing to take an antacid or H2 blocker medicine, take it at least 2 hours before or 2 hours after Bosuvi. If you take a Proton Pump Inhibitor (PPI) medicine, talk to your healthcare provider.
    • Breastfeeding should be avoided. It can harm your baby. You and your healthcare provider should decide if you will take Bosuvi or breastfeed.
    • Administration of Bosulif should be avoided as it is not known if this medication is safe and effective in children who are less than 18 years of age.
    • Females should use effective birth control (contraception) during and for at least 30 days after the final dose of BOSULIF. Talk to your doctor about forms of birth control that may be right for you during such circumstances.
    • Patients should be advised of the possibility of developing renal problems and to immediately report frequent urination, polyuria or oliguria.

      FAQs – Medicine Questions

      Bosutinib Tablets 500 mg
      What is Chronic Myelogenous Leukemia (or chronic myeloid leukemia)?

      Chronic Myelogenous Leukemia, also known as chronic myeloid leukemia, is a cancer of the white blood cells. Such cancers are treated with tyrosine kinase inhibitors such as Bosutinib

      What are tyrosine kinase inhibitors?

      Tyrosine kinase inhibitor is a pharmaceutical drug that inhibits the enzyme Tyrosine kinases, responsible for activating many proteins by signal transduction cascades.

      How to take the medicine Bosutinib?

      Healthcare professionals recommend taking medicine orally with food. Swallow the whole tablet, do not break or cut.

      Where can I buy Bosutinib Tablets

      You can buy Bosutinib Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

      The buyer should check the existing law in their home country before importing the product.

      What is the procedure to buy Bosutinib Tablets?

      Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 99292 77766 / 98738 10020   We will reply ASAP with the details of the Bosutinib Tablets price as well as procurement procedure.

      Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.


      1. Pfizer Europe MA EEIG, Electronic medicines compendium (emc), [ Revised on Dec 2020] [ Accessed on 16th June 2021], https://www.medicines.org.uk/emc/files/pil.3147.pdf
      2. Pfizer, US Food and Drug Administration, [ Revised on April 2017] [ Accessed on 16th June 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/20334s007s008lbl.pdf
      3. Gunhild keller et al; Bosutinib; Recent Results in Cancer Research; Published on 2010; Accessed on 16/06/2021; https://pubmed.ncbi.nlm.nih.gov/20072835/
      Alternative Brands For Bosutinib Tablets 500 mg In India

      To be sold by retail on prescription of a registered doctor only (Bosutinib) tablets, for oral use.